Whether you are healthy or have a medical condition, there are opportunities to participate in a research study. Health research ranges from simple questionnaires or screening tests, to clinical trials of a new drug or device.
The purpose of this study is to collect neurocognitive data from healthy, non-MS, untreated controls to aid in the interpretation of data acquired from treatment trials using both individual neurocognitive test scores and the MS-COG composite score. Cognitive function in healthy controls will be
Recent evidence suggests a connection between the gut and the brain, and that certain conditions in the gut might be associated with neurological diseases. Research suggests that people with Alzheimer's Disease differ from healthy controls with respect to the bacteria (microbiome) present in the
This study aims at testing visual abilities and eye movements in patients with Parkinson’s disease. In order to determine effects of healthy aging on these functions, we are looking for healthy volunteers to serve as a control group.
Target enrollment is 1000 prospectively enrolled subjects with an initial negative biopsy scheduled for repeat biopsy.
Subjects must have had their negative index prostate biopsy procedure within 30 months of being scheduled for their repeat biopsy.
tDCS (transcranial Direct Current Stimulation) is a brain stimulation technique that involves passing a very low current through the scalp to change the excitability of underlying brain regions. Moreover, yoga and meditation have recently gained popularity for their proposed health benefits.
The goal of the current study is to determine the prevalence, rate, and types of pregnancy complications and early life events that may be associated with the emergence of psychosis and related metabolic disorder in patients with schizophrenia spectrum disorders.
To determine how much noise is required during testing to make sure that each ear is assessed separately during an auditory assessment in infants.
MS is a disabling neurological disease with a highly variable clinical course including acute disability (relapses when symptoms appear or worsen) and disease progression (steady accumulation of disability in the absence of relapses). There is currently no approved treatment for progressive MS.